American Vanguard Corporation (AVD) reported QQ1 2025 results that reflect the industry-wide destocking cycle and ongoing portfolio adjustments as the company accelerates its transformation plan. Revenue was $116.0 million, down 14% year over year and 30% quarter over quarter, with adjusted EBITDA of $3.0 million versus $15.5 million in the year-ago period. The reported EBITDA was modest at $0.2 million, highlighting the distinction between GAAP EBITDA and management’s adjusted measure used in guidance discussions. The quarter was characterized by continued destocking, absence of a voluntarily canceled herbicide (Dacthal) from the portfolio, and adverse geographic factors (weak Mexican agave market; drought in Australia). Management underscored that channel inventories in the U.S. are at historic lows and that replenishment appears underway but remains uncertain in timing. Metam sodium (+14% YoY) and Thimet (+17% YoY) emerged as notable positive contributors, reflecting product resilience and geographic demand shifts (peanuts and corn dynamics).
Management guided 2025 revenue to $535–$545 million and adjusted EBITDA to $40–$44 million, down from prior expectations due to the weak first quarter and cautious outlook. They emphasized cost containment, net working capital improvements (operating working capital down $86 million versus a year ago), and a leaner operating model as the pillars of the transformation that should materialize into higher returns over the cycle. In the near term, the company expects CapEx of $8–$9 million and plans to deploy virtually all free cash flow to debt reduction. While near-term profitability remains pressured, the long-term objective of achieving a 15% adjusted EBITDA margin through the cycle remains intact, supported by ongoing portfolio optimization and geographic execution (notably Brazil) where margin contribution has improved despite top-line softness.
Investors should monitor (i) the pace of destocking unwind and channel replenishment, (ii) the trajectory of Metam sodium and Thimet demand in the back half of 2025, (iii) customer acceptance of the ERP integration and its impact on cost structure, and (iv) tariff and agricultural pricing developments that could alter the competitive landscape. The combination of a still-challenging near term and a constructive longer-term plan defines AVD’s risk-reward in a cyclical crop-protection market.